文献速递衰弱、肌少症与跌倒认知障碍与谵妄老年综合评估

养老院居民参与药物与疫苗临床试验招募的障碍与促进因素:范围综述

Barriers and facilitators to recruiting older adult care home residents into clinical trials of medicines and vaccines: a scoping review.
PubMed 文献 · Age Ageing · 2026-01-01

该范围综述纳入8篇文献(2002至2021年,来自美国、英国和法国),采用乔安娜布里格斯研究所方法学,识别养老院居民参与药物和疫苗临床试验招募的障碍与促进因素。筛选失败率范围为18%至96%。障碍与促进因素涉及研究设计、选择标准、招募方法、数据收集方法、参与者保留、居民与家庭相关因素、养老院机构与员工相关因素、医疗专业人员参与、后勤与运营因素、知情同意相关因素、伦理与监管考量、保险与试验成本以及试验结果的可推广性。

要点

  • 养老院居民被排除在药物和疫苗临床试验之外导致证据缺口。
  • 筛选失败率范围为18%至96%,提示招募难度差异大。
  • 障碍与促进因素涉及研究设计、选择标准、招募方法、知情同意及伦理监管等多层面。

核心结论

  • 本综述专门识别了养老院居民参与药物临床试验招募的关键障碍与促进因素,可指导试验规划并支持对该脆弱人群的循证照护。

研究设计与样本

  • 作为Widening Access to Trials in Care Homes项目的一部分,采用乔安娜布里格斯研究所方法学开展范围综述。
  • 检索EMBASE、MEDLINE、PsycINFO、CINAHL和Cochrane Library(1990年至2025年1月)。
  • 从14,301条记录中纳入8篇文章(2002至2021年),来自美国(N=4)、英国(N=3)和法国(N=1)。
  • 纳入文献中6项为随机对照试验,2项分别为定性子研究和问卷调查。

主要发现

  • 筛选失败率范围为18%至96%。
  • 识别的障碍与促进因素主题包括研究设计、选择标准、招募方法、数据收集方法、参与者保留、养老院居民与家庭相关因素、养老院机构与员工相关因素、医疗专业人员参与、后勤与运营因素、知情同意相关因素、伦理与监管考量、保险与试验成本以及试验结果的可推广性。

关键数值与推荐

  • 筛选失败率范围为18%至96%。
  • 纳入8篇文章,来自美国(N=4)、英国(N=3)和法国(N=1),发表时间为2002至2021年。
  • 检索数据库包括EMBASE、MEDLINE、PsycINFO、CINAHL和Cochrane Library,检索时间范围为1990年至2025年1月。

临床怎么用

  • 试验规划时应考虑本综述识别的障碍与促进因素,以优化养老院居民的招募策略。
  • 针对筛选失败率范围较宽的情况,需关注选择标准和研究设计对招募的影响。
  • 应重视知情同意、伦理监管、保险与试验成本等操作层面因素对招募的影响。

局限性

  • 纳入文献仅8篇,来自美国、英国和法国,地理范围有限。
  • 纳入研究类型包括随机对照试验、定性子研究和问卷调查,证据类型不一。
  • 本综述为范围综述,未报告定量合并分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Excluding Care Home (CH) residents from clinical trials of medicines and vaccines has led to an evidence gap. Findings from younger adults may not be generalisable to CH residents with frailty and dementia. Therefore, it is essential to evaluate pharmacological treatments directly in CH residents to assess their safety and efficacy. METHODS: As part of the Widening Access to Trials in Care Homes project, we conducted a scoping review using Joanna Briggs Institute methodology to identify barriers and facilitators to recruiting CH residents into clinical trials of medicinal products. We searched EMBASE, MEDLINE, PsycINFO, CINAHL, and the Cochrane Library (1990 to January 2025). Quantitative data on screen failures and dropouts, and qualitative data on trial teams' real-world experiences and stakeholder perspectives were extracted, synthesised into themes and presented as descriptive summaries. RESULTS: From 14,301 records, eight articles were included (2002 to 2021) from the USA (N = 4), UK (N = 3) and France (N = 1). Six were RCTs, and two were a qualitative sub-study and a questionnaire survey. Screen failure rates ranged from 18% to 96%. Identified themes of barriers and facilitators were study design, selection criteria, recruitment methods, data collection methods, participant retention, CH resident and family-related factors, CH facility and staff-related factors, healthcare professional involvement, logistical and operational factors, consent-related factors, ethical and regulatory considerations, insurance and trial costs, and generalisability of trial results. CONCLUSIONS: Our review specifically identified key barriers and facilitators to recruiting CH residents into pharmacological trials. These findings can guide trial planning and support evidence-based care for this vulnerable population.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Subbarayan S, Smith-Dodd I, Nicolson G, et al. Barriers and facilitators to recruiting older adult care home residents into clinical trials of medicines and vaccines: a scoping review. Age Ageing. 2026. PMID: 41965248. doi:10.1093/ageing/afag077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。